Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
MANKIND Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Moderate ROE but declining trend
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
High operating margin but declining trend
Low Debt to Equity but increasing
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
MANKIND Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
MANKIND Bulk, Block & Insider Trades
MANKIND Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It also offers pet care, cro... Read More
Key personnel
Mr. Ramesh JunejaD
Executive Chairman of the Board
Mr. Sheetal AroraD
Chief Executive Officer, Whole-Time Director
Mr. Rajeev JunejaD
Executive Vice Chairman of the Board, Managing Director
Mr. Ashutosh Dhawan
Global Chief Financial Officer
Mr. Prakash Agarwal
President - Strategy
Mr. Atish Majumdar
Senior President - Sales and Marketing
Dr. Birendra Singh
Senior President - Global Quality Head
Mr. Abhay Kumar Srivastava
Senior President - Operations
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Mankind Pharma Ltd.?
The current share price of Mankind Pharma Ltd. is ₹ 2,200.28 as of 09 Jan 2026.
What is the PE ratio of Mankind Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Mankind Pharma Ltd. is 51.88 as of the latest financial data.
What is the ROE and ROCE of Mankind Pharma Ltd.?
Mankind Pharma Ltd. has a Return on Equity (ROE) of 13.55% and a Return on Capital Employed (ROCE) of 13.68% as per the latest financial reports.
What is the market cap of Mankind Pharma Ltd.?
The market capitalization of Mankind Pharma Ltd. stands at ₹ 90,828.70 Cr.
What is the dividend yield of Mankind Pharma Ltd.?
The dividend yield of Mankind Pharma Ltd. is 0.05% based on the current market price.
What is the RSI of Mankind Pharma Ltd.?
The Relative Strength Index (RSI) of Mankind Pharma Ltd. is 48.54.
What is the FII and DII holding in Mankind Pharma Ltd.?
Foreign Institutional Investors (FII) hold 12.83% and Domestic Institutional Investors (DII) hold 9.55% of Mankind Pharma Ltd. shares.
What sector does Mankind Pharma Ltd. belong to?
Mankind Pharma Ltd. operates in the Healthcare sector.
What is the beta of Mankind Pharma Ltd. stock?
The beta of Mankind Pharma Ltd. stock is 0.72, indicating its volatility relative to the broader market.
